Literature DB >> 3392208

Multiple components of the A1 adenosine receptor-adenylate cyclase system are regulated in rat cerebral cortex by chronic caffeine ingestion.

V Ramkumar1, J R Bumgarner, K A Jacobson, G L Stiles.   

Abstract

The effects of chronic caffeine on the A1 adenosine receptor-adenylate cyclase system of rat cerebral cortical membranes were studied. Caffeine treatment significantly increased the number of A1 adenosine receptors as determined with the A1 adenosine receptor antagonist radioligand [3H]xanthine amine congener (XAC). R-PIA (agonist) competition curves constructed with [3H]XAC were most appropriately described by a two affinity state model in control membranes with a KH of 2.1 +/- 0.8 and a KL of 404 +/- 330 nM with 50 +/- 4% of receptors in the high affinity state (%RH). In contrast, in membranes from treated animals, there was a marked shift towards the high affinity state. In three of seven animals all of the receptors were shifted to a unique high affinity state which was indistinguishable from the KH observed in membranes from control animals. In four of seven animals the %RH increased from 50 to 69% with KH and KL indistinguishable from the control values. Thus, the agonist specific high affinity form of the receptor was enhanced following caffeine treatment. Maximal inhibition of adenylate cyclase activity in cerebral cortical membranes by R-PIA (1 microM) was significantly increased by 28% following caffeine treatment, consistent with an increased coupling of receptor-Gi protein with adenylate cyclase. Importantly, the quantity of Gi (alpha i) in rat cerebral cortex, determined by pertussis toxin-mediated labeling, was also increased to 133% of control values by this treatment. Thus, multiple components and interactions of the A1 adenosine receptor-adenylate cyclase complex are regulated by caffeine. These changes are likely compensatory measures to offset blockade of A1 receptors in vivo by caffeine and lead to a sensitization of this inhibitory receptor system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3392208      PMCID: PMC303500          DOI: 10.1172/JCI113577

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Single-dose tolerance to the behavioral effects of dibutyryl cyclic AMP in mice.

Authors:  M Weiner; J W Olson
Journal:  Psychopharmacology (Berl)       Date:  1977-08-31       Impact factor: 4.530

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis.

Authors:  C Londos; D M Cooper; W Schlegel; M Rodbell
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

Review 4.  Caffeine--its identity, dietary sources, intake and biological effects.

Authors:  D M Graham
Journal:  Nutr Rev       Date:  1978-04       Impact factor: 7.110

5.  Adenosine modulation of synaptosomal dopamine release.

Authors:  M L Michaelis; E K Michaelis; S L Myers
Journal:  Life Sci       Date:  1979-05-28       Impact factor: 5.037

6.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

7.  Protective effect of adenosine and nicotinamide against audiogenic seizure.

Authors:  M Maitre; L Chesielski; A Lehmann; E Kempf; P Mandel
Journal:  Biochem Pharmacol       Date:  1974-10-15       Impact factor: 5.858

8.  Effects of catecholamines and adenosine derivatives given into the brain of fowls.

Authors:  E Marley; G Nistico
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

9.  Cholera toxin ADP-ribosylates the islet-activating protein substrate in adipocyte membranes and alters its function.

Authors:  J R Owens; L T Frame; M Ui; D M Cooper
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

10.  The A1 adenosine receptor. Identification of the binding subunit by photoaffinity cross-linking.

Authors:  G L Stiles; D T Daly; R A Olsson
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

View more
  19 in total

1.  Chronic effects of xanthines on levels of central receptors in mice.

Authors:  D Shi; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

2.  The Effects of Dietary Caffeine Use and Abstention on Blood Oxygen Level-Dependent Activation and Cerebral Blood Flow.

Authors:  Merideth A Addicott; Ann M Peiffer; Paul J Laurienti
Journal:  J Caffeine Res       Date:  2012-03

3.  Cloning, expression, and characterization of the unique bovine A1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis.

Authors:  M E Olah; H Ren; J Ostrowski; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

4.  Effects of chronic caffeine on adenosine, dopamine and acetylcholine systems in mice.

Authors:  D Shi; O Nikodijević; K A Jacobson; J W Daly
Journal:  Arch Int Pharmacodyn Ther       Date:  1994 Nov-Dec

5.  Caffeine tolerance is incomplete: persistent blood pressure responses in the ambulatory setting.

Authors:  Noha H Farag; Andrea S Vincent; Bong Hee Sung; Thomas L Whitsett; Michael F Wilson; William R Lovallo
Journal:  Am J Hypertens       Date:  2005-05       Impact factor: 2.689

6.  The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions.

Authors:  P Svenningsson; G G Nomikos; B B Fredholm
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

Review 7.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

8.  Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia.

Authors:  D K Von Lubitz; R C Lin; N Melman; X D Ji; M F Carter; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1994-04-21       Impact factor: 4.432

9.  Effects of chronic administration of adenosine A1 receptor agonist and antagonist on spatial learning and memory.

Authors:  D K Von Lubitz; I A Paul; R T Bartus; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1993-11-16       Impact factor: 4.432

10.  Effects of Long-Term Caffeine Consumption on the Adenosine A1 Receptor in the Rat Brain: an In Vivo PET Study with [18F]CPFPX.

Authors:  Danje Nabbi-Schroeter; David Elmenhorst; Angela Oskamp; Stefanie Laskowski; Andreas Bauer; Tina Kroll
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.